Zhejiang Xianju Pharmaceutical Co., Ltd. (002332)
Market Open
7 Aug, 06:57
XSHE XSHE Primary ¥
8. 54
+0.08
+0.9456%
¥
9.14B Market Cap
- P/E Ratio
0.4% Div Yield
12.36M Volume
- Eps
¥ 8.46
Previous Close Want to track 002332 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
002332 trading today higher at ¥8.54, an increase of 0.9456% from yesterday's close, completing a monthly increase of 6.3512% or ¥0.51. Over the past 12 months, 002332 stock lost -5.3215%.
002332 pays dividends to its shareholders, with the most recent payment made on May 28, 2026. The next estimated payment will be in In 3 months on Nov 28, 2026 for a total of ¥0.2.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0817%, based on the last three reports.
Zhejiang Xianju Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 18, 2017.
The company's stock is traded on one exchange.
Zhejiang Xianju Pharmaceutical Co., Ltd. (002332) FAQ
What is the stock price today?
The current price is ¥8.54.
On which exchange is it traded?
Zhejiang Xianju Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 002332.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.4%.
What is its market cap?
As of today, the market cap is 9.14B.
Has Zhejiang Xianju Pharmaceutical Co., Ltd. ever had a stock split?
Zhejiang Xianju Pharmaceutical Co., Ltd. had 2 splits and the recent split was on May 18, 2017.
Zhejiang Xianju Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Weihua Jin CEO | XSHE Exchange | CNE100000K64 ISIN |
| CN Country | 3,205 Employees | 28 May 2026 Last Dividend | 18 May 2017 Last Split | 12 Jan 2010 IPO Date |
Overview
Zhejiang Xianju Pharmaceutical Co., Ltd. is a reputable company based in Xianju, China, that specializes in the manufacture and worldwide sale of steroids and hormones. Since its establishment in 1972, the company has been providing a broad range of pharmaceutical products focusing on gynecological, anesthesia, respiratory, dermatology, and generic drugs. Their extensive experience and dedication to quality have positioned them as a leading provider in the pharmaceutical industry, catering to both domestic and international markets.
Products and Services
- Gynecological Products: These are designed to address various conditions affecting the female reproductive system, offering solutions for health issues ranging from menstrual disorders to hormonal imbalances.
- Anesthesia Products: Zhejiang Xianju Pharmaceutical provides a range of anesthesia products used in surgical procedures to induce temporary loss of sensation or awareness, ensuring patient comfort and pain management during operations.
- Respiratory Products: Aimed at treating respiratory conditions, these products help manage and alleviate symptoms associated with diseases of the lungs and airways, such as asthma, chronic bronchitis, and COPD.
- Dermatology Products: This category includes treatments for various skin conditions and diseases, offering solutions for issues ranging from simple skin irritations to more complex dermatological conditions.
- Generic Drugs: The company produces a wide range of generic drugs, providing affordable alternatives to brand-name medications without compromising on quality or efficacy.
- Active Pharmaceutical Ingredients (API): Zhejiang Xianju Pharmaceutical specializes in the production of APIs, including corticosteroids, sex hormones, and progesterone, as well as non-hormone series, newchem API, and intermediates. These ingredients are crucial in the development and manufacture of various drugs, showcasing the company's capability in the pharmaceutical supply chain.
Contact Information
Address: No. 1 Xianyao Road, Xianju, China, 317306
Phone: 86 57 68773 1138
Website: https://www.xjpharma.com
